ID: MRFR/HC/5058-HCR | 90 Pages | Author: Rahul Gotadki | March 2024
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Atrial Fibrillation Market, by Type
6.1 Introduction
6.2 Paroxysmal Atrial Fibrillation
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Persistent Atrial Fibrillation
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Permanent Atrial Fibrillation
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Atrial Fibrillation Market, by Treatment
7.1 Introduction
7.2 Medications
7.2.1 Blood Thinners
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2 Rate controllers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.3 Rhythm controllers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Non-surgical procedures
7.3.1 Catheter ablation
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.2 Electrical cardioversion
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Surgical procedures
7.4.1 Pacemaker implantation
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4.2 Open-heart maze procedure
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Atrial Fibrillation Market, by End-User
8.1 Introduction
8.2 Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Electrophysiology Labs
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Atrial Fibrillation Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Johnson & Johnson Services, Inc.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Abbott
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Medtronic Plc
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Boston Scientific Corporation
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 MicroPort Scientific Corporation
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Biotronik SE & Co. KG
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Koninklijke Philips N.V.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 AtriCure, Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 CardioFocus
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Osypka AG
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Siemens AG
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Biosense Webster, Inc.
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 CathRx Ltd.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Vanguard AG
11.15.1 Overview
11.15.2 Product Overview
11.15.3 Financials
11.15.4 Key Developments
11.15.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOβs Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Atrial Fibrillation Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Atrial Fibrillation Market Synopsis, 2020β2027
Table 2 Global Atrial Fibrillation Market Estimates and Forecast, 2020-2027(USD Million)
Table 3 Global Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 4 Global Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 5 Global Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 6 Global Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 7 North America: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 8 North America: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 9 North America: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 10 North America: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 11 US: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 12 US: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 13 US: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 14 US: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 15 Canada: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 16 Canada: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 17 Canada: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 18 Canada: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 19 South America: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 20 South America: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 21 South America: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 22 South America: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 23 Europe: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 24 Europe: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 25 Europe: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 26 Europe: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 27 Western Europe: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 28 Western Europe: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 29 Western Europe: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 30 Western Europe: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 31 Eastern Europe: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 32 Eastern Europe: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 33 Eastern Europe: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 34 Eastern Europe: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 35 Asia-Pacific: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 36 Asia-Pacific: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 37 Asia-Pacific: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 38 Asia-Pacific: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
Table 39 Middle East & Africa: Atrial Fibrillation Market, by Type, 2020-2027(USD Million)
Table 40 Middle East & Africa: Atrial Fibrillation Market, by Treatment, 2020-2027(USD Million)
Table 41 Middle East & Africa: Atrial Fibrillation Market, by End-User, 2020-2027(USD Million)
Table 42 Middle East & Africa: Atrial Fibrillation Market, by Region, 2020-2027(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Atrial Fibrillation Market
Figure 3 Segmentation Market Dynamics for Global Atrial Fibrillation Market
Figure 4 Global Atrial Fibrillation Market Share, by Type, 2020 (%)
Figure 5 Global Atrial Fibrillation Market Share, by Treatment, 2020 (%)
Figure 6 Global Atrial Fibrillation Market Share, by End-User, 2020 (%)
Figure 7 Global Atrial Fibrillation Market Share, by Region, 2020 (%)
Figure 8 North America: Atrial Fibrillation Market Share, by Country, 2020 (%)
Figure 9 Europe: Atrial Fibrillation Market Share, by Country, 2020 (%)
Figure 10 Asia-Pacific: Atrial Fibrillation Market Share, by Country, 2020 (%)
Figure 11 Middle East & Africa: Atrial Fibrillation Market Share, by Country, 2020 (%)
Figure 12 Global Atrial Fibrillation Market: Company Share Analysis, 2020 (%)
Figure 13 Johnson & Johnson Services, Inc.: Key Financials
Figure 14 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 15 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 16 Abbott: Key Financials
Figure 17 Abbott: Segmental Revenue
Figure 18 Abbott: Geographical Revenue
Figure 19 Medtronic Plc: Key Financials
Figure 20 Medtronic Plc: Segmental Revenue
Figure 21 Medtronic Plc: Geographical Revenue
Figure 22 Boston Scientific Corporation: Key Financials
Figure 23 Boston Scientific Corporation: Segmental Revenue
Figure 24 Boston Scientific Corporation: Geographical Revenue
Figure 25 MicroPort Scientific Corporation: Key Financials
Figure 26 MicroPort Scientific Corporation: Segmental Revenue
Figure 27 MicroPort Scientific Corporation: Geographical Revenue
Figure 28 Biotronik SE & Co. KG: Key Financials
Figure 29 Biotronik SE & Co. KG: Segmental Revenue
Figure 30 Biotronik SE & Co. KG: Geographical Revenue
Figure 31 Koninklijke Philips N.V.: Key Financials
Figure 32 Koninklijke Philips N.V.: Segmental Revenue
Figure 33 Koninklijke Philips N.V.: Geographical Revenue
Figure 34 AtriCure, Inc.: Key Financials
Figure 35 AtriCure, Inc.: Segmental Revenue
Figure 36 AtriCure, Inc.: Geographical Revenue
Figure 37 CardioFocus: Key Financials
Figure 38 CardioFocus: Segmental Revenue
Figure 39 CardioFocus: Geographical Revenue
Figure 40 Osypka AG: Key Financials
Figure 41 Osypka AG: Segmental Revenue
Figure 42 Osypka AG: Geographical Revenue
Figure 43 Siemens AG: Key Financials
Figure 44 Siemens AG: Segmental Revenue
Figure 45 Siemens AG: Geographical Revenue
Figure 46 Biosense Webster, Inc.: Key Financials
Figure 47 Biosense Webster, Inc.: Segmental Revenue
Figure 48 Biosense Webster, Inc.: Geographical Revenue
Figure 49 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.: Key Financials
Figure 50 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.: Segmental Revenue
Figure 51 Sichuan Jinjiang Electronic Science and Technology Co., Ltd.: Geographical Revenue
Figure 52 CathRx Ltd.: Key Financials
Figure 53 CathRx Ltd.: Segmental Revenue
Figure 54 CathRx Ltd.: Geographical Revenue
Figure 55 Vanguard AG: Key Financials
Figure 56 Vanguard AG: Segmental Revenue
Figure 57 Vanguard AG: Geographical Revenue
Market Segmentation
Atrial Fibrillation Type Outlook (USD Billion, 2019-2030)
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Atrial Fibrillation Treatment Outlook (USD Billion, 2019-2030)
Medications
Non-surgical procedures
Surgical procedures
Atrial Fibrillation End User Outlook (USD Billion, 2019-2030)
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Atrial Fibrillation Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
North America Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
North America Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
US Outlook (USD Billion, 2019-2030)
U.S. Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
U.S. Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
U.S. Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
CANADA Outlook (USD Billion, 2019-2030)
CANADA Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
CANADA Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
CANADA Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Europe Outlook (USD Billion, 2019-2030)
Europe Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Europe Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Europe Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Germany Outlook (USD Billion, 2019-2030)
Germany Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Germany Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Germany Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
France Outlook (USD Billion, 2019-2030)
France Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
France Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
France Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
UK Outlook (USD Billion, 2019-2030)
UK Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
UK Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
UK Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
ITALY Outlook (USD Billion, 2019-2030)
ITALY Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
ITALY Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
ITALY Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
SPAIN Outlook (USD Billion, 2019-2030)
SPAIN Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
SPAIN Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
SPAIN Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Rest Of Europe Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Rest Of Europe Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Asia-Pacific Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Asia-Pacific Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
China Outlook (USD Billion, 2019-2030)
China Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
China Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
China Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Japan Outlook (USD Billion, 2019-2030)
Japan Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Japan Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Japan Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
India Outlook (USD Billion, 2019-2030)
India Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
India Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
India Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Australia Outlook (USD Billion, 2019-2030)
Australia Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Australia Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Australia Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Rest of Asia-Pacific Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Rest of Asia-Pacific Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Rest of the World Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Rest of the World Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Middle East Outlook (USD Billion, 2019-2030)
Middle East Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Middle East Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Middle East Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Africa Outlook (USD Billion, 2019-2030)
Africa Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Africa Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Africa Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers
Latin America Outlook (USD Billion, 2019-2030)
Latin America Atrial Fibrillation by Type
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Permanent atrial fibrillation
Latin America Atrial Fibrillation by Treatment
Medications
Non-surgical procedures
Surgical procedures
Latin America Atrial Fibrillation by End User
Hospitals
Electrophysiology Labs
Ambulatory Surgical Centers